

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | hemidesmosome assembly (GO:0031581) | 4.23362680 |
| 2 | desmosome organization (GO:0002934) | 4.17771281 |
| 3 | hypotonic response (GO:0006971) | 4.07772276 |
| 4 | Golgi transport vesicle coating (GO:0048200) | 3.84632460 |
| 5 | COPI coating of Golgi vesicle (GO:0048205) | 3.84632460 |
| 6 | skin morphogenesis (GO:0043589) | 3.59897925 |
| 7 | protein localization to endosome (GO:0036010) | 3.50575487 |
| 8 | COPII vesicle coating (GO:0048208) | 3.46963468 |
| 9 | angiotensin maturation (GO:0002003) | 3.37353214 |
| 10 | regulation of extracellular matrix disassembly (GO:0010715) | 3.24206757 |
| 11 | phospholipid homeostasis (GO:0055091) | 3.23365696 |
| 12 | regulation of transforming growth factor beta1 production (GO:0032908) | 3.16275283 |
| 13 | peptide catabolic process (GO:0043171) | 3.00904097 |
| 14 | macroautophagy (GO:0016236) | 3.00030340 |
| 15 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 2.98444634 |
| 16 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.84654669 |
| 17 | embryonic process involved in female pregnancy (GO:0060136) | 2.83790398 |
| 18 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 2.81712518 |
| 19 | endodermal cell differentiation (GO:0035987) | 2.76506641 |
| 20 | positive regulation by symbiont of host defense response (GO:0052509) | 2.75999924 |
| 21 | modulation by symbiont of host defense response (GO:0052031) | 2.75999924 |
| 22 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.75999924 |
| 23 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.75999924 |
| 24 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.75999924 |
| 25 | modulation by symbiont of host immune response (GO:0052553) | 2.75999924 |
| 26 | response to laminar fluid shear stress (GO:0034616) | 2.72081085 |
| 27 | sequestering of extracellular ligand from receptor (GO:0035581) | 2.69779265 |
| 28 | surfactant homeostasis (GO:0043129) | 2.68857875 |
| 29 | iron ion import (GO:0097286) | 2.66075552 |
| 30 | positive regulation of p38MAPK cascade (GO:1900745) | 2.63801037 |
| 31 | branching involved in mammary gland duct morphogenesis (GO:0060444) | 2.59358003 |
| 32 | pinocytosis (GO:0006907) | 2.59337138 |
| 33 | intestinal epithelial cell development (GO:0060576) | 2.59004329 |
| 34 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.58468229 |
| 35 | cell-substrate junction assembly (GO:0007044) | 2.58428244 |
| 36 | negative regulation of protein localization to plasma membrane (GO:1903077) | 2.56451015 |
| 37 | membrane protein ectodomain proteolysis (GO:0006509) | 2.56231767 |
| 38 | cellular response to vitamin D (GO:0071305) | 2.55861748 |
| 39 | vesicle coating (GO:0006901) | 2.55770285 |
| 40 | regulation of transforming growth factor beta2 production (GO:0032909) | 2.55177278 |
| 41 | mesodermal cell differentiation (GO:0048333) | 2.55079672 |
| 42 | lipoprotein transport (GO:0042953) | 2.49619570 |
| 43 | cellular ketone body metabolic process (GO:0046950) | 2.49579460 |
| 44 | barbed-end actin filament capping (GO:0051016) | 2.49214967 |
| 45 | membrane raft organization (GO:0031579) | 2.47341182 |
| 46 | negative regulation of fatty acid transport (GO:2000192) | 2.44987168 |
| 47 | ketone body metabolic process (GO:1902224) | 2.42436773 |
| 48 | microglial cell activation (GO:0001774) | 2.42431849 |
| 49 | wound healing, spreading of epidermal cells (GO:0035313) | 2.42396529 |
| 50 | apoptotic cell clearance (GO:0043277) | 2.40735392 |
| 51 | intracellular lipid transport (GO:0032365) | 2.40528156 |
| 52 | I-kappaB phosphorylation (GO:0007252) | 2.40330894 |
| 53 | positive regulation of extracellular matrix organization (GO:1903055) | 2.38597127 |
| 54 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.38115747 |
| 55 | multicellular organismal catabolic process (GO:0044243) | 2.38013067 |
| 56 | cell adhesion mediated by integrin (GO:0033627) | 2.37929442 |
| 57 | positive regulation of endothelial cell apoptotic process (GO:2000353) | 2.37233101 |
| 58 | response to lipoprotein particle (GO:0055094) | 2.36812109 |
| 59 | mammary gland epithelial cell proliferation (GO:0033598) | 2.35837704 |
| 60 | glycosphingolipid catabolic process (GO:0046479) | 2.35818858 |
| 61 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.35116636 |
| 62 | adhesion of symbiont to host cell (GO:0044650) | 2.33356873 |
| 63 | virion attachment to host cell (GO:0019062) | 2.33356873 |
| 64 | epithelial cell-cell adhesion (GO:0090136) | 2.33296273 |
| 65 | multicellular organismal macromolecule metabolic process (GO:0044259) | 2.32352649 |
| 66 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.31541132 |
| 67 | oligosaccharide catabolic process (GO:0009313) | 2.31331005 |
| 68 | negative regulation of lipid storage (GO:0010888) | 2.29803129 |
| 69 | ER overload response (GO:0006983) | 2.29315002 |
| 70 | multicellular organismal metabolic process (GO:0044236) | 2.29058863 |
| 71 | extracellular matrix disassembly (GO:0022617) | 2.28442510 |
| 72 | glycolipid catabolic process (GO:0019377) | 2.27370060 |
| 73 | macrophage activation involved in immune response (GO:0002281) | 2.26227844 |
| 74 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 2.25978079 |
| 75 | regulation of transforming growth factor beta production (GO:0071634) | 2.25828242 |
| 76 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 2.25640594 |
| 77 | detection of molecule of bacterial origin (GO:0032490) | 2.25295699 |
| 78 | regulation of metalloenzyme activity (GO:0048552) | 2.24666864 |
| 79 | negative regulation of keratinocyte proliferation (GO:0010839) | 2.24493736 |
| 80 | regulation of extracellular matrix organization (GO:1903053) | 2.24131633 |
| 81 | collagen metabolic process (GO:0032963) | 2.24070710 |
| 82 | regulation of integrin activation (GO:0033623) | 2.23061144 |
| 83 | keratan sulfate catabolic process (GO:0042340) | 2.22640116 |
| 84 | dichotomous subdivision of an epithelial terminal unit (GO:0060600) | 2.21897316 |
| 85 | chondrocyte proliferation (GO:0035988) | 2.21695769 |
| 86 | pathway-restricted SMAD protein phosphorylation (GO:0060389) | 2.21343687 |
| 87 | collagen catabolic process (GO:0030574) | 2.19876975 |
| 88 | intestinal absorption (GO:0050892) | 2.19799378 |
| 89 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 2.19507462 |
| 90 | regulation of cholesterol homeostasis (GO:2000188) | 2.19270098 |
| 91 | protein targeting to Golgi (GO:0000042) | 2.19137135 |
| 92 | substrate-dependent cell migration (GO:0006929) | 2.18372813 |
| 93 | sphingomyelin metabolic process (GO:0006684) | 2.17640781 |
| 94 | stress fiber assembly (GO:0043149) | 2.17314196 |
| 95 | cellular response to vitamin (GO:0071295) | 2.16908928 |
| 96 | cholesterol efflux (GO:0033344) | 2.16189900 |
| 97 | collagen fibril organization (GO:0030199) | 2.15691189 |
| 98 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.15586101 |
| 99 | negative regulation of establishment of protein localization to plasma membrane (GO:0090005) | 2.14557754 |
| 100 | regulation of platelet-derived growth factor receptor signaling pathway (GO:0010640) | 2.14053605 |
| 101 | protein retention in ER lumen (GO:0006621) | 2.13753072 |
| 102 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition | 2.13740659 |
| 103 | establishment of protein localization to Golgi (GO:0072600) | 2.13530019 |
| 104 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S tr | 2.13370865 |
| 105 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.13370580 |
| 106 | adhesion of symbiont to host (GO:0044406) | 2.13136350 |
| 107 | reverse cholesterol transport (GO:0043691) | 2.11914449 |
| 108 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 2.11887900 |
| 109 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 2.11867057 |
| 110 | positive regulation of receptor recycling (GO:0001921) | 2.11334468 |
| 111 | positive regulation of cholesterol efflux (GO:0010875) | 2.11051407 |
| 112 | melanin biosynthetic process (GO:0042438) | 2.10933284 |
| 113 | negative regulation of complement activation (GO:0045916) | 2.10813962 |
| 114 | negative regulation of anoikis (GO:2000811) | 2.10312047 |
| 115 | regulation of macrophage derived foam cell differentiation (GO:0010743) | 2.10124071 |
| 116 | phospholipid efflux (GO:0033700) | 2.09915110 |
| 117 | fatty acid transmembrane transport (GO:1902001) | 2.08894827 |
| 118 | negative regulation of epidermal growth factor-activated receptor activity (GO:0007175) | 2.07189199 |
| 119 | endocytic recycling (GO:0032456) | 2.06010754 |
| 120 | protein carboxylation (GO:0018214) | 2.05555087 |
| 121 | peptidyl-glutamic acid carboxylation (GO:0017187) | 2.05555087 |
| 122 | fibril organization (GO:0097435) | 2.05475168 |
| 123 | inner ear receptor cell development (GO:0060119) | 2.05374767 |
| 124 | retrograde transport, vesicle recycling within Golgi (GO:0000301) | 2.04824217 |
| 125 | positive regulation of blood vessel endothelial cell migration (GO:0043536) | 2.03491272 |
| 126 | positive regulation of glycolytic process (GO:0045821) | 2.03218231 |
| 127 | viral entry into host cell (GO:0046718) | 2.02979560 |
| 128 | very-low-density lipoprotein particle assembly (GO:0034379) | 2.02948537 |
| 129 | regulation of chemokine secretion (GO:0090196) | 2.02037577 |
| 130 | wound healing (GO:0042060) | 2.01852359 |
| 131 | regulation of keratinocyte differentiation (GO:0045616) | 2.01782658 |
| 132 | regulation of sequestering of triglyceride (GO:0010889) | 2.01457510 |
| 133 | lung lobe morphogenesis (GO:0060463) | 2.00294620 |
| 134 | secondary metabolite biosynthetic process (GO:0044550) | 1.99654789 |
| 135 | hyaluronan catabolic process (GO:0030214) | 1.99479614 |
| 136 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 1.99196410 |
| 137 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 1.99004332 |
| 138 | relaxation of cardiac muscle (GO:0055119) | 1.98819944 |
| 139 | fibroblast migration (GO:0010761) | 1.98754589 |
| 140 | macrophage activation (GO:0042116) | 1.98348310 |
| 141 | lipoprotein metabolic process (GO:0042157) | 1.97974189 |
| 142 | tyrosine metabolic process (GO:0006570) | 1.96935146 |
| 143 | regulation of p38MAPK cascade (GO:1900744) | 1.96453057 |
| 144 | positive regulation of sterol transport (GO:0032373) | 1.96200633 |
| 145 | positive regulation of cholesterol transport (GO:0032376) | 1.96200633 |
| 146 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 1.94689571 |
| 147 | alanine transport (GO:0032328) | 1.94511618 |
| 148 | plasma lipoprotein particle clearance (GO:0034381) | 1.92830855 |
| 149 | cytoplasmic mRNA processing body assembly (GO:0033962) | 1.92718537 |
| 150 | mannose metabolic process (GO:0006013) | 1.92085518 |
| 151 | carnitine shuttle (GO:0006853) | 1.91578575 |
| 152 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 1.91246916 |
| 153 | positive regulation of epidermal growth factor-activated receptor activity (GO:0045741) | 1.90934740 |
| 154 | low-density lipoprotein particle clearance (GO:0034383) | 1.89290542 |
| 155 | urea cycle (GO:0000050) | 1.88191724 |
| 156 | urea metabolic process (GO:0019627) | 1.88191724 |
| 157 | response to host immune response (GO:0052572) | 1.87342357 |
| 158 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 1.87342357 |
| 159 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 1.86727495 |
| 160 | regulation of cholesterol storage (GO:0010885) | 1.86572437 |
| 161 | regulation of transcription from RNA polymerase II promoter in response to oxidative stress (GO:0043 | 1.86010909 |
| 162 | Golgi to endosome transport (GO:0006895) | 1.85205395 |
| 163 | melanin metabolic process (GO:0006582) | 1.85136938 |
| 164 | cholesterol transport (GO:0030301) | 1.84604407 |
| 165 | sterol transport (GO:0015918) | 1.84604407 |
| 166 | regulation of energy homeostasis (GO:2000505) | 1.84555704 |
| 167 | negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642) | 1.83840913 |
| 168 | positive regulation of macrophage cytokine production (GO:0060907) | 1.83118225 |
| 169 | negative regulation of protein activation cascade (GO:2000258) | 1.82209497 |
| 170 | negative regulation of neurotransmitter secretion (GO:0046929) | 1.82158317 |
| 171 | neuron remodeling (GO:0016322) | 1.82154398 |
| 172 | bile acid and bile salt transport (GO:0015721) | 1.82068241 |
| 173 | endoplasmic reticulum organization (GO:0007029) | 1.81695526 |
| 174 | homocysteine metabolic process (GO:0050667) | 1.81214649 |
| 175 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 1.80168067 |
| 176 | metanephric mesenchyme development (GO:0072075) | 1.79546328 |
| 177 | drug catabolic process (GO:0042737) | 1.78901392 |
| 178 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 1.78094718 |
| 179 | complement activation, alternative pathway (GO:0006957) | 1.77260220 |
| 180 | import into cell (GO:0098657) | 1.75761060 |
| 181 | insulin-like growth factor receptor signaling pathway (GO:0048009) | 1.75466309 |
| 182 | L-phenylalanine catabolic process (GO:0006559) | 1.73852458 |
| 183 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 1.73852458 |
| 184 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 1.73760284 |
| 185 | growth hormone receptor signaling pathway (GO:0060396) | 1.72944902 |
| 186 | phospholipid translocation (GO:0045332) | 1.72744932 |
| 187 | lipid translocation (GO:0034204) | 1.72744932 |
| 188 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 1.72185496 |
| 189 | response to host defenses (GO:0052200) | 1.72185496 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 4.91696503 |
| 2 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.41744032 |
| 3 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.68759450 |
| 4 | * SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 2.53894577 |
| 5 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.51907281 |
| 6 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.17348136 |
| 7 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.15018954 |
| 8 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.05842134 |
| 9 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.05352772 |
| 10 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.03956449 |
| 11 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.03732519 |
| 12 | * SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 2.02898436 |
| 13 | * SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 2.02898436 |
| 14 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.00519669 |
| 15 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.97870359 |
| 16 | * SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.94718584 |
| 17 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.93967650 |
| 18 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.91401761 |
| 19 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.84975281 |
| 20 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.82685012 |
| 21 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.82271904 |
| 22 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.82148516 |
| 23 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.81769520 |
| 24 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.78670340 |
| 25 | * NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.73204001 |
| 26 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.71869836 |
| 27 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.70798487 |
| 28 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.70732257 |
| 29 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.70167741 |
| 30 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.68283919 |
| 31 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.68044586 |
| 32 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.67466708 |
| 33 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.64166178 |
| 34 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.52232035 |
| 35 | * FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.52110381 |
| 36 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.51253106 |
| 37 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.50734916 |
| 38 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.50734916 |
| 39 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.50374821 |
| 40 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.48818036 |
| 41 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.48491177 |
| 42 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.46667681 |
| 43 | TP53_16413492_ChIP-PET_HCT116_Human | 1.45395005 |
| 44 | BRD4_25478319_ChIP-Seq_HGPS_Human | 1.45167156 |
| 45 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.43485837 |
| 46 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.42720208 |
| 47 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.41305916 |
| 48 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.41224699 |
| 49 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.40532714 |
| 50 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.40509440 |
| 51 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 1.39625081 |
| 52 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.38924251 |
| 53 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.38468774 |
| 54 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.37676873 |
| 55 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.37333312 |
| 56 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.37109899 |
| 57 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.36490712 |
| 58 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.36092875 |
| 59 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.36054066 |
| 60 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.35381800 |
| 61 | CJUN_26792858_Chip-Seq_BT549_Human | 1.33218621 |
| 62 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.31549274 |
| 63 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.30733503 |
| 64 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.30280875 |
| 65 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.29865071 |
| 66 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.29407536 |
| 67 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.28488252 |
| 68 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.25996698 |
| 69 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.25658881 |
| 70 | P300_19829295_ChIP-Seq_ESCs_Human | 1.25015355 |
| 71 | STAT3_23295773_ChIP-Seq_U87_Human | 1.24995648 |
| 72 | AR_25329375_ChIP-Seq_VCAP_Human | 1.24870103 |
| 73 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.24420881 |
| 74 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.22851032 |
| 75 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.22682851 |
| 76 | RXR_22108803_ChIP-Seq_LS180_Human | 1.21962076 |
| 77 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.21866834 |
| 78 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.21654873 |
| 79 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.20895441 |
| 80 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.19581268 |
| 81 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.19154121 |
| 82 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.18416860 |
| 83 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.17905436 |
| 84 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.17490142 |
| 85 | * JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.17433241 |
| 86 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.16571659 |
| 87 | * SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.16409547 |
| 88 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.14649844 |
| 89 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.14376814 |
| 90 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.14138408 |
| 91 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.13743219 |
| 92 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.11801048 |
| 93 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.11647340 |
| 94 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.11604657 |
| 95 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.11519225 |
| 96 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.11250143 |
| 97 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.11030573 |
| 98 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.10731960 |
| 99 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.09928333 |
| 100 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.08966414 |
| 101 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.08927476 |
| 102 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.08047737 |
| 103 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.07333369 |
| 104 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.07258636 |
| 105 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.07257876 |
| 106 | * TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.07094715 |
| 107 | * JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.06146319 |
| 108 | * UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.05473907 |
| 109 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.05263416 |
| 110 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.04935949 |
| 111 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.04935949 |
| 112 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.03846757 |
| 113 | * NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.03392537 |
| 114 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.03079319 |
| 115 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.02755618 |
| 116 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.02295179 |
| 117 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.01522722 |
| 118 | * GATA2_19941826_ChIP-Seq_K562_Human | 1.01520360 |
| 119 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 1.01123613 |
| 120 | * MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.00790516 |
| 121 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.00769160 |
| 122 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.00566103 |
| 123 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.00522279 |
| 124 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.00298769 |
| 125 | * TP63_23658742_ChIP-Seq_EP156T_Human | 0.99636723 |
| 126 | TCF4_23295773_ChIP-Seq_U87_Human | 0.98860863 |
| 127 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 0.98801533 |
| 128 | * RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.98615649 |
| 129 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.98305331 |
| 130 | GATA1_22025678_ChIP-Seq_K562_Human | 0.97864765 |
| 131 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.96318349 |
| 132 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.95906192 |
| 133 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.95113905 |
| 134 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 0.95020456 |
| 135 | EOMES_20176728_ChIP-ChIP_TSCs_Mouse | 0.94978359 |
| 136 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.94873770 |
| 137 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.94488869 |
| 138 | SPI1_23127762_ChIP-Seq_K562_Human | 0.94103633 |
| 139 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.94067963 |
| 140 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.92912956 |
| 141 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.92517229 |
| 142 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.92072515 |
| 143 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 0.91816713 |
| 144 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.91045173 |
| 145 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.90785010 |
| 146 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.90561103 |
| 147 | KLF5_25053715_ChIP-Seq_YYC3_Human | 0.89739808 |
| 148 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.89475643 |
| 149 | * EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.89356927 |
| 150 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.89265007 |
| 151 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.87122133 |
| 152 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.86999428 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0000569_abnormal_digit_pigmentation | 5.67775693 |
| 2 | MP0005058_abnormal_lysosome_morphology | 3.35905114 |
| 3 | MP0005360_urolithiasis | 3.05863461 |
| 4 | MP0005670_abnormal_white_adipose | 2.76630399 |
| 5 | MP0003566_abnormal_cell_adhesion | 2.63245411 |
| 6 | MP0002139_abnormal_hepatobiliary_system | 2.62367957 |
| 7 | MP0010352_gastrointestinal_tract_polyps | 2.62325514 |
| 8 | MP0008438_abnormal_cutaneous_collagen | 2.62280746 |
| 9 | MP0003183_abnormal_peptide_metabolism | 2.45018719 |
| 10 | MP0003172_abnormal_lysosome_physiology | 2.40659872 |
| 11 | MP0006054_spinal_hemorrhage | 2.32890783 |
| 12 | MP0009780_abnormal_chondrocyte_physiolo | 2.02524232 |
| 13 | MP0010386_abnormal_urinary_bladder | 2.02303891 |
| 14 | MP0004043_abnormal_pH_regulation | 2.01999693 |
| 15 | MP0003252_abnormal_bile_duct | 1.99988894 |
| 16 | MP0005257_abnormal_intraocular_pressure | 1.98186403 |
| 17 | MP0003300_gastrointestinal_ulcer | 1.97130187 |
| 18 | MP0005365_abnormal_bile_salt | 1.95395913 |
| 19 | MP0003690_abnormal_glial_cell | 1.92561222 |
| 20 | MP0005171_absent_coat_pigmentation | 1.88314629 |
| 21 | MP0003705_abnormal_hypodermis_morpholog | 1.83161153 |
| 22 | MP0005409_darkened_coat_color | 1.81846101 |
| 23 | MP0003045_fibrosis | 1.81368117 |
| 24 | MP0003191_abnormal_cellular_cholesterol | 1.80080367 |
| 25 | MP0005023_abnormal_wound_healing | 1.79626694 |
| 26 | MP0003279_aneurysm | 1.72459793 |
| 27 | MP0000372_irregular_coat_pigmentation | 1.62455443 |
| 28 | MP0003941_abnormal_skin_development | 1.62137822 |
| 29 | MP0009840_abnormal_foam_cell | 1.60805523 |
| 30 | MP0002796_impaired_skin_barrier | 1.60394930 |
| 31 | MP0000015_abnormal_ear_pigmentation | 1.58065998 |
| 32 | MP0010329_abnormal_lipoprotein_level | 1.56783885 |
| 33 | MP0004130_abnormal_muscle_cell | 1.53982823 |
| 34 | MP0010155_abnormal_intestine_physiology | 1.50523671 |
| 35 | MP0000013_abnormal_adipose_tissue | 1.50405572 |
| 36 | MP0004947_skin_inflammation | 1.48964204 |
| 37 | MP0005666_abnormal_adipose_tissue | 1.45365132 |
| 38 | MP0005408_hypopigmentation | 1.43442890 |
| 39 | MP0005085_abnormal_gallbladder_physiolo | 1.42643019 |
| 40 | MP0000538_abnormal_urinary_bladder | 1.41151433 |
| 41 | MP0009384_cardiac_valve_regurgitation | 1.36792138 |
| 42 | MP0000858_altered_metastatic_potential | 1.33519664 |
| 43 | MP0004272_abnormal_basement_membrane | 1.33037515 |
| 44 | MP0003436_decreased_susceptibility_to | 1.31960197 |
| 45 | MP0004782_abnormal_surfactant_physiolog | 1.31936244 |
| 46 | MP0000003_abnormal_adipose_tissue | 1.30023461 |
| 47 | MP0002877_abnormal_melanocyte_morpholog | 1.29242140 |
| 48 | MP0005375_adipose_tissue_phenotype | 1.27962369 |
| 49 | MP0008260_abnormal_autophagy | 1.27758038 |
| 50 | MP0003195_calcinosis | 1.27041130 |
| 51 | MP0000604_amyloidosis | 1.26429039 |
| 52 | MP0005164_abnormal_response_to | 1.26256188 |
| 53 | MP0001216_abnormal_epidermal_layer | 1.26058079 |
| 54 | MP0008875_abnormal_xenobiotic_pharmacok | 1.25258825 |
| 55 | MP0002118_abnormal_lipid_homeostasis | 1.23456574 |
| 56 | MP0005464_abnormal_platelet_physiology | 1.21711170 |
| 57 | MP0001958_emphysema | 1.21657514 |
| 58 | MP0003868_abnormal_feces_composition | 1.20503846 |
| 59 | MP0001873_stomach_inflammation | 1.20140089 |
| 60 | MP0000465_gastrointestinal_hemorrhage | 1.19737036 |
| 61 | MP0001666_abnormal_nutrient_absorption | 1.17860035 |
| 62 | MP0004885_abnormal_endolymph | 1.17297279 |
| 63 | MP0001849_ear_inflammation | 1.17155674 |
| 64 | MP0008004_abnormal_stomach_pH | 1.16849747 |
| 65 | MP0000371_diluted_coat_color | 1.16161284 |
| 66 | MP0005275_abnormal_skin_tensile | 1.15621533 |
| 67 | MP0000427_abnormal_hair_cycle | 1.15083335 |
| 68 | MP0004270_analgesia | 1.13501000 |
| 69 | MP0003828_pulmonary_edema | 1.13091251 |
| 70 | MP0004264_abnormal_extraembryonic_tissu | 1.13012760 |
| 71 | MP0001299_abnormal_eye_distance/ | 1.11362984 |
| 72 | MP0003950_abnormal_plasma_membrane | 1.11090057 |
| 73 | MP0002909_abnormal_adrenal_gland | 1.09365599 |
| 74 | MP0002009_preneoplasia | 1.09207762 |
| 75 | MP0002998_abnormal_bone_remodeling | 1.09086616 |
| 76 | MP0000767_abnormal_smooth_muscle | 1.08976531 |
| 77 | MP0001533_abnormal_skeleton_physiology | 1.07398570 |
| 78 | MP0010368_abnormal_lymphatic_system | 1.07258934 |
| 79 | MP0005334_abnormal_fat_pad | 1.05171615 |
| 80 | MP0003091_abnormal_cell_migration | 1.05055528 |
| 81 | MP0001835_abnormal_antigen_presentation | 1.04155532 |
| 82 | MP0002896_abnormal_bone_mineralization | 1.02445689 |
| 83 | MP0005332_abnormal_amino_acid | 1.02434417 |
| 84 | MP0010678_abnormal_skin_adnexa | 1.02011386 |
| 85 | MP0005310_abnormal_salivary_gland | 1.00080834 |
| 86 | MP0002098_abnormal_vibrissa_morphology | 0.99572277 |
| 87 | MP0002168_other_aberrant_phenotype | 0.99514559 |
| 88 | MP0005166_decreased_susceptibility_to | 0.99140678 |
| 89 | MP0003448_altered_tumor_morphology | 0.98228922 |
| 90 | MP0005503_abnormal_tendon_morphology | 0.98115960 |
| 91 | MP0001324_abnormal_eye_pigmentation | 0.97556462 |
| 92 | MP0004185_abnormal_adipocyte_glucose | 0.97384298 |
| 93 | MP0000627_abnormal_mammary_gland | 0.96837925 |
| 94 | MP0002295_abnormal_pulmonary_circulatio | 0.96490140 |
| 95 | MP0000609_abnormal_liver_physiology | 0.95869400 |
| 96 | MP0002876_abnormal_thyroid_physiology | 0.95850928 |
| 97 | MP0002971_abnormal_brown_adipose | 0.95485345 |
| 98 | MP0005501_abnormal_skin_physiology | 0.94955762 |
| 99 | MP0005645_abnormal_hypothalamus_physiol | 0.94583749 |
| 100 | MP0004883_abnormal_blood_vessel | 0.94015812 |
| 101 | MP0000383_abnormal_hair_follicle | 0.93648499 |
| 102 | MP0002090_abnormal_vision | 0.92641115 |
| 103 | MP0000462_abnormal_digestive_system | 0.91898055 |
| 104 | MP0003866_abnormal_defecation | 0.90344543 |
| 105 | MP0001661_extended_life_span | 0.89071107 |
| 106 | MP0004742_abnormal_vestibular_system | 0.88871664 |
| 107 | MP0002166_altered_tumor_susceptibility | 0.88521396 |
| 108 | MP0010234_abnormal_vibrissa_follicle | 0.88517035 |
| 109 | MP0001881_abnormal_mammary_gland | 0.87951518 |
| 110 | MP0006082_CNS_inflammation | 0.87891693 |
| 111 | MP0000477_abnormal_intestine_morphology | 0.87759139 |
| 112 | MP0001243_abnormal_dermal_layer | 0.87609962 |
| 113 | MP0003724_increased_susceptibility_to | 0.86969503 |
| 114 | MP0005387_immune_system_phenotype | 0.84701506 |
| 115 | MP0001790_abnormal_immune_system | 0.84701506 |
| 116 | MP0000685_abnormal_immune_system | 0.84613887 |
| 117 | MP0002138_abnormal_hepatobiliary_system | 0.83504539 |
| 118 | MP0000467_abnormal_esophagus_morphology | 0.82117263 |
| 119 | MP0001845_abnormal_inflammatory_respons | 0.81951261 |
| 120 | MP0002136_abnormal_kidney_physiology | 0.81735790 |
| 121 | MP0003795_abnormal_bone_structure | 0.81718292 |
| 122 | MP0009785_altered_susceptibility_to | 0.80840708 |
| 123 | MP0001915_intracranial_hemorrhage | 0.80174493 |
| 124 | MP0002078_abnormal_glucose_homeostasis | 0.80171013 |
| 125 | MP0005165_increased_susceptibility_to | 0.79765516 |
| 126 | MP0001542_abnormal_bone_strength | 0.78824574 |
| 127 | MP0002060_abnormal_skin_morphology | 0.78434043 |
| 128 | MP0005451_abnormal_body_composition | 0.78194112 |
| 129 | MP0000249_abnormal_blood_vessel | 0.78082339 |
| 130 | MP0001501_abnormal_sleep_pattern | 0.78016249 |
| 131 | MP0009643_abnormal_urine_homeostasis | 0.77065130 |
| 132 | MP0001502_abnormal_circadian_rhythm | 0.76917272 |
| 133 | MP0000377_abnormal_hair_follicle | 0.76430697 |
| 134 | MP0002928_abnormal_bile_duct | 0.75724149 |
| 135 | MP0003634_abnormal_glial_cell | 0.75381095 |
| 136 | MP0005377_hearing/vestibular/ear_phenot | 0.75363431 |
| 137 | MP0003878_abnormal_ear_physiology | 0.75363431 |
| 138 | MP0005197_abnormal_uvea_morphology | 0.75338655 |
| 139 | MP0001851_eye_inflammation | 0.75187552 |
| 140 | MP0001756_abnormal_urination | 0.74637183 |
| 141 | MP0000230_abnormal_systemic_arterial | 0.74044469 |
| 142 | MP0001440_abnormal_grooming_behavior | 0.74019713 |
| 143 | MP0002254_reproductive_system_inflammat | 0.73776938 |
| 144 | MP0005025_abnormal_response_to | 0.73065885 |
| 145 | MP0005535_abnormal_body_temperature | 0.72544832 |
| 146 | MP0001765_abnormal_ion_homeostasis | 0.72090047 |
| 147 | MP0002006_tumorigenesis | 0.71764181 |
| 148 | MP0005379_endocrine/exocrine_gland_phen | 0.70141785 |
| 149 | MP0001177_atelectasis | 0.69087958 |
| 150 | MP0004019_abnormal_vitamin_homeostasis | 0.68850150 |
| 151 | MP0002419_abnormal_innate_immunity | 0.68154567 |
| 152 | MP0003453_abnormal_keratinocyte_physiol | 0.67272053 |
| 153 | MP0009764_decreased_sensitivity_to | 0.67215764 |
| 154 | MP0002108_abnormal_muscle_morphology | 0.66651018 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Alopecia of scalp (HP:0002293) | 3.75048035 |
| 2 | Atrophic scars (HP:0001075) | 3.62864263 |
| 3 | Protrusio acetabuli (HP:0003179) | 3.57226551 |
| 4 | Flat acetabular roof (HP:0003180) | 3.54840938 |
| 5 | Conjugated hyperbilirubinemia (HP:0002908) | 3.50547084 |
| 6 | Right ventricular cardiomyopathy (HP:0011663) | 3.09197899 |
| 7 | Cervical subluxation (HP:0003308) | 3.08406886 |
| 8 | Submucous cleft hard palate (HP:0000176) | 3.06456975 |
| 9 | Follicular hyperkeratosis (HP:0007502) | 2.95543803 |
| 10 | Hematochezia (HP:0002573) | 2.93335524 |
| 11 | Dysostosis multiplex (HP:0000943) | 2.90224200 |
| 12 | Myocardial infarction (HP:0001658) | 2.73435884 |
| 13 | Fragile skin (HP:0001030) | 2.72695305 |
| 14 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.68853117 |
| 15 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.68853117 |
| 16 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.68853117 |
| 17 | Blue irides (HP:0000635) | 2.64219735 |
| 18 | Systemic lupus erythematosus (HP:0002725) | 2.62688731 |
| 19 | Malnutrition (HP:0004395) | 2.60730729 |
| 20 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.54796953 |
| 21 | Mucopolysacchariduria (HP:0008155) | 2.54796953 |
| 22 | Complement deficiency (HP:0004431) | 2.53444470 |
| 23 | Vacuolated lymphocytes (HP:0001922) | 2.52251051 |
| 24 | Xanthomatosis (HP:0000991) | 2.50469306 |
| 25 | Hyperactive renin-angiotensin system (HP:0000841) | 2.49531585 |
| 26 | Eczematoid dermatitis (HP:0000976) | 2.47376932 |
| 27 | Mitral stenosis (HP:0001718) | 2.42059882 |
| 28 | Aplasia/Hypoplasia of the macula (HP:0008059) | 2.39032922 |
| 29 | Hyperlipoproteinemia (HP:0010980) | 2.37047872 |
| 30 | Arterial tortuosity (HP:0005116) | 2.35706446 |
| 31 | Glomerulonephritis (HP:0000099) | 2.34589380 |
| 32 | Peripheral demyelination (HP:0011096) | 2.33426162 |
| 33 | Chronic diarrhea (HP:0002028) | 2.30976059 |
| 34 | Dilatation of the ascending aorta (HP:0005111) | 2.30834675 |
| 35 | Cardiovascular calcification (HP:0011915) | 2.30492406 |
| 36 | Generalized hypopigmentation of hair (HP:0011358) | 2.30120111 |
| 37 | Increased cerebral lipofuscin (HP:0011813) | 2.29641954 |
| 38 | Ankyloglossia (HP:0010296) | 2.28870580 |
| 39 | Neonatal short-limb short stature (HP:0008921) | 2.28236486 |
| 40 | Milia (HP:0001056) | 2.28154339 |
| 41 | Retinal atrophy (HP:0001105) | 2.27862498 |
| 42 | Segmental peripheral demyelination/remyelination (HP:0003481) | 2.26273791 |
| 43 | Hyperglycemia (HP:0003074) | 2.25812609 |
| 44 | Aplasia/Hypoplasia affecting the retina (HP:0008061) | 2.25063475 |
| 45 | Thick nail (HP:0001805) | 2.22073396 |
| 46 | Aneurysm (HP:0002617) | 2.21544916 |
| 47 | Neurofibrillary tangles (HP:0002185) | 2.19918834 |
| 48 | Thin bony cortex (HP:0002753) | 2.19798033 |
| 49 | Decreased circulating renin level (HP:0003351) | 2.19356028 |
| 50 | Prostate neoplasm (HP:0100787) | 2.18711239 |
| 51 | Peritonitis (HP:0002586) | 2.18381258 |
| 52 | Onycholysis (HP:0001806) | 2.16677256 |
| 53 | Hydroxyprolinuria (HP:0003080) | 2.14206822 |
| 54 | Abnormality of proline metabolism (HP:0010907) | 2.14206822 |
| 55 | Onion bulb formation (HP:0003383) | 2.13360893 |
| 56 | Abnormality of carpal bone ossification (HP:0006257) | 2.11503684 |
| 57 | Wormian bones (HP:0002645) | 2.10785407 |
| 58 | Plantar hyperkeratosis (HP:0007556) | 2.10715307 |
| 59 | Hypoalphalipoproteinemia (HP:0003233) | 2.09767062 |
| 60 | Global brain atrophy (HP:0002283) | 2.09407750 |
| 61 | Vertebral compression fractures (HP:0002953) | 2.09045378 |
| 62 | Abnormality of chloride homeostasis (HP:0011422) | 2.08512109 |
| 63 | Deep venous thrombosis (HP:0002625) | 2.08313072 |
| 64 | Progressive visual loss (HP:0000529) | 2.07556809 |
| 65 | Axonal loss (HP:0003447) | 2.07335531 |
| 66 | Soft skin (HP:0000977) | 2.06569182 |
| 67 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.06411520 |
| 68 | Blue sclerae (HP:0000592) | 2.05959799 |
| 69 | Vascular tortuosity (HP:0004948) | 2.04714406 |
| 70 | Aortic aneurysm (HP:0004942) | 2.02713489 |
| 71 | Vascular calcification (HP:0004934) | 2.01732693 |
| 72 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.00954023 |
| 73 | Hyperkalemia (HP:0002153) | 1.99453726 |
| 74 | Abnormality of oral frenula (HP:0000190) | 1.98982300 |
| 75 | Abnormality of the acetabulum (HP:0003170) | 1.97606275 |
| 76 | Fat malabsorption (HP:0002630) | 1.97190187 |
| 77 | Severe short stature (HP:0003510) | 1.96939280 |
| 78 | Macroorchidism (HP:0000053) | 1.96282636 |
| 79 | Curly hair (HP:0002212) | 1.95477390 |
| 80 | Premature rupture of membranes (HP:0001788) | 1.95281689 |
| 81 | Abnormality of the ischium (HP:0003174) | 1.94675049 |
| 82 | Increased CSF protein (HP:0002922) | 1.94025819 |
| 83 | Skin nodule (HP:0200036) | 1.93170867 |
| 84 | Abnormality of glycolipid metabolism (HP:0010969) | 1.92775153 |
| 85 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.92775153 |
| 86 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.92775153 |
| 87 | Supranuclear gaze palsy (HP:0000605) | 1.92571146 |
| 88 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.92544267 |
| 89 | Ovoid vertebral bodies (HP:0003300) | 1.92297761 |
| 90 | Abdominal distention (HP:0003270) | 1.92198821 |
| 91 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.90930453 |
| 92 | Cubitus valgus (HP:0002967) | 1.89589053 |
| 93 | Loss of speech (HP:0002371) | 1.88800030 |
| 94 | Fair hair (HP:0002286) | 1.88176623 |
| 95 | Absent frontal sinuses (HP:0002688) | 1.86920807 |
| 96 | Progressive sensorineural hearing impairment (HP:0000408) | 1.85853282 |
| 97 | Bladder diverticulum (HP:0000015) | 1.84759643 |
| 98 | Congenital sensorineural hearing impairment (HP:0008527) | 1.84604833 |
| 99 | Ulnar claw (HP:0001178) | 1.84134021 |
| 100 | Cerebral inclusion bodies (HP:0100314) | 1.83694008 |
| 101 | Nephritis (HP:0000123) | 1.83163206 |
| 102 | Joint hemorrhage (HP:0005261) | 1.82425068 |
| 103 | Abnormal ossification of hand bones (HP:0005921) | 1.81472728 |
| 104 | Mitral valve prolapse (HP:0001634) | 1.81395843 |
| 105 | Abnormality of the common coagulation pathway (HP:0010990) | 1.81176223 |
| 106 | Thoracolumbar scoliosis (HP:0002944) | 1.81080641 |
| 107 | Long toe (HP:0010511) | 1.80145725 |
| 108 | Pheochromocytoma (HP:0002666) | 1.79978443 |
| 109 | J-shaped sella turcica (HP:0002680) | 1.77917227 |
| 110 | Abnormality of macrophages (HP:0004311) | 1.77709199 |
| 111 | Esophageal varix (HP:0002040) | 1.77585756 |
| 112 | Spondylolisthesis (HP:0003302) | 1.77578823 |
| 113 | Increased connective tissue (HP:0009025) | 1.77538002 |
| 114 | Natal tooth (HP:0000695) | 1.76975791 |
| 115 | Recurrent bacterial skin infections (HP:0005406) | 1.76284951 |
| 116 | Abnormal foot bone ossification (HP:0010675) | 1.76253329 |
| 117 | Coarse hair (HP:0002208) | 1.76080591 |
| 118 | Tetraparesis (HP:0002273) | 1.75579662 |
| 119 | Protuberant abdomen (HP:0001538) | 1.74916419 |
| 120 | Epidermoid cyst (HP:0200040) | 1.74724564 |
| 121 | Cupped ribs (HP:0000887) | 1.74719309 |
| 122 | Febrile seizures (HP:0002373) | 1.73654343 |
| 123 | Abnormality of dentin (HP:0010299) | 1.73164661 |
| 124 | Femoral bowing (HP:0002980) | 1.73059127 |
| 125 | Ankle contracture (HP:0006466) | 1.72965503 |
| 126 | Aortic dissection (HP:0002647) | 1.72415383 |
| 127 | Short nail (HP:0001799) | 1.71987047 |
| 128 | Abnormality of complement system (HP:0005339) | 1.71754166 |
| 129 | Periodontitis (HP:0000704) | 1.71475034 |
| 130 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.71281749 |
| 131 | Osteolytic defects of the hand bones (HP:0009699) | 1.71281749 |
| 132 | Abnormality of vision evoked potentials (HP:0000649) | 1.71158531 |
| 133 | Thickened calvaria (HP:0002684) | 1.70892773 |
| 134 | Abnormality of primary teeth (HP:0006481) | 1.70519770 |
| 135 | Abnormal hand bone ossification (HP:0010660) | 1.70335380 |
| 136 | Termporal pattern (HP:0011008) | 1.69972572 |
| 137 | Insidious onset (HP:0003587) | 1.69972572 |
| 138 | Aplasia/Hypoplasia of the frontal sinuses (HP:0009119) | 1.69309224 |
| 139 | Tibial bowing (HP:0002982) | 1.69222091 |
| 140 | Abnormality of the distal phalanges of the toes (HP:0010182) | 1.69069331 |
| 141 | Prolonged partial thromboplastin time (HP:0003645) | 1.68688779 |
| 142 | Premature loss of primary teeth (HP:0006323) | 1.68111045 |
| 143 | Cerebral aneurysm (HP:0004944) | 1.68008315 |
| 144 | Hypophosphatemia (HP:0002148) | 1.66908652 |
| 145 | Turricephaly (HP:0000262) | 1.66286574 |
| 146 | Bone pain (HP:0002653) | 1.65326007 |
| 147 | Gingivitis (HP:0000230) | 1.65194735 |
| 148 | Aplasia involving bones of the upper limbs (HP:0009823) | 1.64941727 |
| 149 | Aplasia of the phalanges of the hand (HP:0009802) | 1.64941727 |
| 150 | Aplasia involving bones of the extremities (HP:0009825) | 1.64941727 |
| 151 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 1.64917495 |
| 152 | Hypoplasia of dental enamel (HP:0006297) | 1.64695809 |
| 153 | Coxa vara (HP:0002812) | 1.64440504 |
| 154 | Pathologic fracture (HP:0002756) | 1.64194503 |
| 155 | Disinhibition (HP:0000734) | 1.63776987 |
| 156 | Flared iliac wings (HP:0002869) | 1.63509179 |
| 157 | Broad face (HP:0000283) | 1.62912428 |
| 158 | Palmoplantar hyperkeratosis (HP:0000972) | 1.62817261 |
| 159 | Spontaneous hematomas (HP:0007420) | 1.61894941 |
| 160 | Joint laxity (HP:0001388) | 1.61850646 |
| 161 | Spinal cord lesions (HP:0100561) | 1.61453439 |
| 162 | Syringomyelia (HP:0003396) | 1.61453439 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TNIK | 3.43995656 |
| 2 | MKNK2 | 3.37221041 |
| 3 | ERN1 | 2.92898788 |
| 4 | EPHA2 | 2.86779048 |
| 5 | CAMK1D | 2.82234716 |
| 6 | LATS1 | 2.71709767 |
| 7 | FRK | 2.57661946 |
| 8 | CAMK1G | 2.51793706 |
| 9 | TAOK3 | 2.35393298 |
| 10 | SIK3 | 2.31559936 |
| 11 | AKT3 | 2.31021787 |
| 12 | RIPK4 | 2.17582672 |
| 13 | MAP3K13 | 2.15109643 |
| 14 | MAP3K14 | 1.92654947 |
| 15 | MYLK | 1.92430631 |
| 16 | INSRR | 1.90923851 |
| 17 | RIPK1 | 1.89731034 |
| 18 | STK24 | 1.85159814 |
| 19 | IRAK3 | 1.72860185 |
| 20 | SCYL2 | 1.70324544 |
| 21 | SGK2 | 1.67338910 |
| 22 | MAP3K12 | 1.59491166 |
| 23 | MAPK15 | 1.51066530 |
| 24 | PAK4 | 1.45463169 |
| 25 | STK39 | 1.44384928 |
| 26 | MST1R | 1.43050127 |
| 27 | SGK494 | 1.42729668 |
| 28 | SGK223 | 1.42729668 |
| 29 | BLK | 1.41692625 |
| 30 | ZAP70 | 1.35155887 |
| 31 | ACVR1B | 1.34518296 |
| 32 | SGK3 | 1.32910942 |
| 33 | PKN2 | 1.32495151 |
| 34 | JAK1 | 1.32433208 |
| 35 | MAP3K2 | 1.28907092 |
| 36 | MAP3K3 | 1.28593213 |
| 37 | FER | 1.27271395 |
| 38 | TRPM7 | 1.22469293 |
| 39 | WNK1 | 1.19010109 |
| 40 | SIK1 | 1.18747870 |
| 41 | BRD4 | 1.15876687 |
| 42 | JAK3 | 1.13976203 |
| 43 | NEK9 | 1.11987593 |
| 44 | BMPR1B | 1.09295814 |
| 45 | PRKG2 | 1.08960847 |
| 46 | NUAK1 | 1.08481595 |
| 47 | YES1 | 1.08283083 |
| 48 | MST4 | 1.07536782 |
| 49 | CDC42BPA | 1.06597866 |
| 50 | PLK2 | 1.06286974 |
| 51 | BCR | 1.05146182 |
| 52 | TYK2 | 1.04446585 |
| 53 | CSF1R | 1.04096160 |
| 54 | NTRK1 | 1.03647111 |
| 55 | MKNK1 | 1.02657591 |
| 56 | TGFBR2 | 1.02107355 |
| 57 | KSR1 | 1.01920143 |
| 58 | CAMKK2 | 1.01107084 |
| 59 | MAP3K6 | 1.00859726 |
| 60 | MARK3 | 0.97963119 |
| 61 | PTK6 | 0.97944956 |
| 62 | TESK1 | 0.96494756 |
| 63 | STK38 | 0.95425656 |
| 64 | BMPR2 | 0.94113221 |
| 65 | LMTK2 | 0.91780279 |
| 66 | DDR2 | 0.90884122 |
| 67 | MAP2K4 | 0.90647240 |
| 68 | PDGFRA | 0.90245948 |
| 69 | IRAK1 | 0.87876844 |
| 70 | SGK1 | 0.86481561 |
| 71 | PRKAA2 | 0.85661325 |
| 72 | CDK12 | 0.85577228 |
| 73 | MAPKAPK3 | 0.84843785 |
| 74 | DAPK2 | 0.82585196 |
| 75 | EPHA3 | 0.82162581 |
| 76 | TTN | 0.80788740 |
| 77 | TBK1 | 0.78285727 |
| 78 | EEF2K | 0.77190660 |
| 79 | EIF2AK3 | 0.77187188 |
| 80 | ERBB4 | 0.74916074 |
| 81 | PRPF4B | 0.74844982 |
| 82 | MAP3K4 | 0.73860510 |
| 83 | PIK3CA | 0.73189909 |
| 84 | STK3 | 0.73094874 |
| 85 | PRKCE | 0.72882421 |
| 86 | CDK9 | 0.72379971 |
| 87 | EPHB1 | 0.71409636 |
| 88 | PDGFRB | 0.71144373 |
| 89 | TRIM28 | 0.70574319 |
| 90 | GRK7 | 0.68727334 |
| 91 | MAP3K1 | 0.68273141 |
| 92 | FGFR2 | 0.67729387 |
| 93 | PIK3CG | 0.67205519 |
| 94 | RPS6KA2 | 0.67096282 |
| 95 | GRK6 | 0.66879946 |
| 96 | WNK3 | 0.66466490 |
| 97 | NEK6 | 0.65157167 |
| 98 | NTRK3 | 0.64706294 |
| 99 | IKBKE | 0.64697393 |
| 100 | FGR | 0.64468427 |
| 101 | MELK | 0.64277889 |
| 102 | MAP2K3 | 0.63532910 |
| 103 | PTK2B | 0.61123990 |
| 104 | MAP3K9 | 0.60913368 |
| 105 | RET | 0.60672696 |
| 106 | MET | 0.60167542 |
| 107 | PRKAA1 | 0.60067395 |
| 108 | LATS2 | 0.59049715 |
| 109 | PDPK1 | 0.58573546 |
| 110 | FGFR3 | 0.57932994 |
| 111 | MAP2K7 | 0.56845068 |
| 112 | MAP3K5 | 0.56105013 |
| 113 | PRKCH | 0.55462163 |
| 114 | MAP3K10 | 0.54349608 |
| 115 | KSR2 | 0.54075679 |
| 116 | STK38L | 0.52790656 |
| 117 | PAK2 | 0.52785848 |
| 118 | PTK2 | 0.52641254 |
| 119 | MAP3K7 | 0.50995732 |
| 120 | EPHB2 | 0.50345917 |
| 121 | JAK2 | 0.49554478 |
| 122 | SIK2 | 0.49528228 |
| 123 | MAP2K1 | 0.49252390 |
| 124 | WNK4 | 0.49067540 |
| 125 | CHUK | 0.47879522 |
| 126 | TEC | 0.47775918 |
| 127 | PKN1 | 0.47383871 |
| 128 | CDK6 | 0.46230928 |
| 129 | MATK | 0.45614520 |
| 130 | FGFR4 | 0.45354268 |
| 131 | MAPKAPK2 | 0.45298348 |
| 132 | NLK | 0.44995866 |
| 133 | STK10 | 0.44019114 |
| 134 | MAPK7 | 0.43133876 |
| 135 | GSK3A | 0.42993661 |
| 136 | PDK1 | 0.42642604 |
| 137 | EPHA4 | 0.42194768 |
| 138 | HIPK2 | 0.41248571 |
| 139 | KIT | 0.40954523 |
| 140 | MAPK12 | 0.40927881 |
| 141 | IGF1R | 0.40869129 |
| 142 | CSK | 0.40057825 |
| 143 | TRIB3 | 0.39743835 |
| 144 | ERBB3 | 0.39413908 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.84209074 |
| 2 | Renin-angiotensin system_Homo sapiens_hsa04614 | 1.82985461 |
| 3 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.75811312 |
| 4 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.61634265 |
| 5 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.55698493 |
| 6 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.53422841 |
| 7 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.44352763 |
| 8 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.42328519 |
| 9 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.40099175 |
| 10 | Lysosome_Homo sapiens_hsa04142 | 1.39734356 |
| 11 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.39615361 |
| 12 | Mineral absorption_Homo sapiens_hsa04978 | 1.32378736 |
| 13 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.30782850 |
| 14 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.30304100 |
| 15 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.29606103 |
| 16 | Galactose metabolism_Homo sapiens_hsa00052 | 1.27296619 |
| 17 | Lysine degradation_Homo sapiens_hsa00310 | 1.26398971 |
| 18 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 1.23638266 |
| 19 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.22888487 |
| 20 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.21421690 |
| 21 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.17217733 |
| 22 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.15036222 |
| 23 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.10458393 |
| 24 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.10216018 |
| 25 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.09851166 |
| 26 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.09459642 |
| 27 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.07473522 |
| 28 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.05166520 |
| 29 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.04183338 |
| 30 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.03997857 |
| 31 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.03542824 |
| 32 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.03158399 |
| 33 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.02750745 |
| 34 | ABC transporters_Homo sapiens_hsa02010 | 1.02485680 |
| 35 | Bile secretion_Homo sapiens_hsa04976 | 1.01154151 |
| 36 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.99932847 |
| 37 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.99913601 |
| 38 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.97661100 |
| 39 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.96827040 |
| 40 | Bladder cancer_Homo sapiens_hsa05219 | 0.95977449 |
| 41 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.95244608 |
| 42 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.91908574 |
| 43 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.91270492 |
| 44 | Other glycan degradation_Homo sapiens_hsa00511 | 0.91181028 |
| 45 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.89658316 |
| 46 | Platelet activation_Homo sapiens_hsa04611 | 0.88639976 |
| 47 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.87879933 |
| 48 | Insulin resistance_Homo sapiens_hsa04931 | 0.87861656 |
| 49 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.87826868 |
| 50 | Peroxisome_Homo sapiens_hsa04146 | 0.87733728 |
| 51 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.87615377 |
| 52 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.87411500 |
| 53 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.87342216 |
| 54 | Circadian rhythm_Homo sapiens_hsa04710 | 0.85796671 |
| 55 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.85265082 |
| 56 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.85215953 |
| 57 | Phagosome_Homo sapiens_hsa04145 | 0.85206081 |
| 58 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.84978052 |
| 59 | Thyroid cancer_Homo sapiens_hsa05216 | 0.84751708 |
| 60 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.84443663 |
| 61 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.83956437 |
| 62 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.83326573 |
| 63 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.83176733 |
| 64 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.82449720 |
| 65 | Influenza A_Homo sapiens_hsa05164 | 0.81702082 |
| 66 | Shigellosis_Homo sapiens_hsa05131 | 0.80760099 |
| 67 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.80298975 |
| 68 | Histidine metabolism_Homo sapiens_hsa00340 | 0.79879926 |
| 69 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.79374117 |
| 70 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.78708530 |
| 71 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.78697922 |
| 72 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.78127994 |
| 73 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.77760140 |
| 74 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.77454449 |
| 75 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.76486426 |
| 76 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.76053308 |
| 77 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.75999361 |
| 78 | Endometrial cancer_Homo sapiens_hsa05213 | 0.75199412 |
| 79 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.75036769 |
| 80 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.75028136 |
| 81 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.75005345 |
| 82 | Tuberculosis_Homo sapiens_hsa05152 | 0.74952332 |
| 83 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.74544464 |
| 84 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.70737943 |
| 85 | Insulin secretion_Homo sapiens_hsa04911 | 0.69446881 |
| 86 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.67121096 |
| 87 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.66853147 |
| 88 | Hepatitis B_Homo sapiens_hsa05161 | 0.66661231 |
| 89 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.66461557 |
| 90 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.66010369 |
| 91 | Prion diseases_Homo sapiens_hsa05020 | 0.65830794 |
| 92 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.65455276 |
| 93 | Allograft rejection_Homo sapiens_hsa05330 | 0.65334052 |
| 94 | Taste transduction_Homo sapiens_hsa04742 | 0.64802488 |
| 95 | Endocytosis_Homo sapiens_hsa04144 | 0.64670015 |
| 96 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.64505209 |
| 97 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.64362411 |
| 98 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.63353874 |
| 99 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.63021119 |
| 100 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.62603394 |
| 101 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.62487402 |
| 102 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.61992360 |
| 103 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.61675345 |
| 104 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.61472048 |
| 105 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.60915061 |
| 106 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.60624986 |
| 107 | Asthma_Homo sapiens_hsa05310 | 0.60513769 |
| 108 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.59990266 |
| 109 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.59980033 |
| 110 | Renin secretion_Homo sapiens_hsa04924 | 0.59956831 |
| 111 | Salmonella infection_Homo sapiens_hsa05132 | 0.58570990 |
| 112 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.58516122 |
| 113 | Measles_Homo sapiens_hsa05162 | 0.58177932 |
| 114 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.57524430 |
| 115 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.57177432 |
| 116 | Amoebiasis_Homo sapiens_hsa05146 | 0.57066080 |
| 117 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.57046706 |
| 118 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.57016181 |
| 119 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.56716680 |
| 120 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.56543443 |
| 121 | Viral myocarditis_Homo sapiens_hsa05416 | 0.56206190 |
| 122 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.56160742 |
| 123 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.56046489 |
| 124 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.55998341 |
| 125 | Nicotine addiction_Homo sapiens_hsa05033 | 0.54892560 |
| 126 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.54844585 |
| 127 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.54797912 |
| 128 | Morphine addiction_Homo sapiens_hsa05032 | 0.54568040 |
| 129 | GABAergic synapse_Homo sapiens_hsa04727 | 0.54333279 |
| 130 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.53130773 |
| 131 | Salivary secretion_Homo sapiens_hsa04970 | 0.52756881 |
| 132 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.52508168 |
| 133 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.51736123 |
| 134 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.51679527 |
| 135 | Pertussis_Homo sapiens_hsa05133 | 0.51522510 |
| 136 | Hepatitis C_Homo sapiens_hsa05160 | 0.49777161 |
| 137 | Malaria_Homo sapiens_hsa05144 | 0.49556481 |
| 138 | Adherens junction_Homo sapiens_hsa04520 | 0.49527084 |
| 139 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.48588246 |
| 140 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.48513182 |
| 141 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.48190252 |
| 142 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.48036740 |
| 143 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.47495268 |
| 144 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.46269806 |
| 145 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.46056837 |
| 146 | Prostate cancer_Homo sapiens_hsa05215 | 0.45085444 |
| 147 | Melanoma_Homo sapiens_hsa05218 | 0.44780325 |
| 148 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.43740057 |
| 149 | Focal adhesion_Homo sapiens_hsa04510 | 0.43149942 |
| 150 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.42990390 |
| 151 | Circadian entrainment_Homo sapiens_hsa04713 | 0.42265910 |
| 152 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.42210385 |
| 153 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.41484261 |
| 154 | Leishmaniasis_Homo sapiens_hsa05140 | 0.41297320 |

